AMPLITUDE THERAPEUTICS: LILLY TO GET EXCLUSIVE, TARGET-SPECIFIC RIGHTS TO DEVELOP ,COMMERCIALIZE LICENSED PRODUCTS DIRECTED TO COLLABORATION TARGETS

Reuters · 1d ago

Please log in to view news